Allegedly for more than a billion dollars. There is no confirmation.
According to a newspaper report, the British-Swedish pharmaceutical company AstraZeneca has sold its stake in the US biotech company Moderna. AstraZeneca sold its 7.7 percent stake for more than $ 1 billion after shares in the US pharmaceutical company soared over the coronavirus vaccine breakthrough, The Times reported on Sunday.
A partnership between the two biotechnology companies would remain in place for other treatments, the report said. Moderna, whose vaccine is approved in the US for emergency use, expects sales of $ 18.4 billion in 2021 due to the vaccine. Both AstraZeneca and Moderna initially did not respond to requests for comment.
Three corona vaccines are approved in the USA: In addition to the Moderna product, the vaccine from the Mainz-based pharmaceutical company BioNTech and its US partner Pfizer and, as of today, Sunday, also the vaccine from the US company Johnson & Johnson. In the EU, the vaccines from BioNTech / Pfizer, Moderna and AstraZeneca are on the market. The EU Commission has ordered vaccination doses for 200 million people from Johnson & Johnson.
